Skip to content
Wenlo
Sign in
← Markets

Guardant Health, Inc.

Guardant Health, Inc. (GH) — Form 144: Proposed sale of shares

144GHFiled Nov 16, 2026, 11:51 AM ET

AI-generated summary

Director Tariq Musa of Guardant Health, Inc. proposed to sell 116 shares of common stock with an aggregate market value of $17,349 through broker Charles Schwab & Co., Inc. The shares were originally acquired through a restricted stock lapse on September 15, 2026. The proposed sale is scheduled for November 16, 2026.

Key facts

Seller
Tariq Musa
Relationship
Director
Shares to sell
116
Market value
$17,349.00
Approximate sale date
Nov 16, 2026
Broker
Charles Schwab & Co., Inc.
Acquired
Sep 15, 2026 · Restricted Stock Lapse

Rule 10b5-1 plan · adopted Dec 17, 2025

More GH filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.